Skip to content

Contribution of SuPAR for Patients in a Situation of Uncertainty Downstream of Emergencies

Contribution of SuPAR for Patients in a Situation of Uncertainty Downstream of Emergencies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05214534
Acronym
SuPAR
Enrollment
202
Registered
2022-01-28
Start date
2022-01-10
Completion date
2022-04-18
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease, Emergencies, In-hospital Observation

Keywords

Supar, Patient triage, Emergency

Brief summary

In this study, the investigators will investigate the relationship between the blood level of SuPAR at admission to the emergency department of the Clermont-Ferrand University Hospital, and the outcome of patients after their hospitalization in a short stay unit.

Detailed description

SuPAR (Soluble urokinase Plasminogen Activator Receptor) is a non-specific prognostic blood biomarker related to inflammation. An elevated SuPAR value reflects significant chronic inflammation and predicts a risk of negative outcome and even short-term mortality (intra-hospital, 30 days, 90 days). Conversely, a low SuPAR value is a strong indicator of good prognosis and low risk of readmission. It is therefore of interest to know a patient's SuPAR blood level to enable the clinician to decide whether the patient should be admitted or discharged. SuPAR has been shown to be the best prognostic marker associated with the presence and progression of disease and risk of mortality. The use of SuPAR in clinical routine adds significant complementary information to the standard Early Warning Score assessment and to the classical parameters such as CRP, PCT, Lactate, ALT, Bilirubin, and CBC in the pre-admission of acute patients. Patients admitted to the emergency department will receive their usual management. We will test the added value of the SuPAR assay in the prognosis of patients' outcome at discharge.

Interventions

OTHERblood supar measurement

The supar values will be measured afterwards on the tube bottoms of the patients included in the study from their usual collection

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient, male or female, over 18 years old * Admitted to the emergency department of the Clermont-Ferrand University Hospital for a medical reason, * Classified as FRENCH II or III by the nurse organizer of the reception management * Necessity of clinical observation in the Short Term Hospitalization Unit for final orientation decision * Requires a blood test upon arrival in the emergency department * Able to give informed non-opposition to participate in the research. * Affiliation to a Social Security system

Exclusion criteria

* Patient under guardianship or curatorship * Pregnant and breast feeding woman * Patient admitted for psychiatric pathology * Patient with a limitation of therapeutics * Refusal to participate * Patient hospitalized because of a particular social context

Design outcomes

Primary

MeasureTime frameDescription
Relationship between blood supar levels and patient outcome at dischargeWhen the excepted 150 patients will be included, estimated 6 monthsRelation between blood supar levels measured and patient outcome at discharge evaluated as : return home = good evolution; hospitalization = bad evolution; admission to an intensive care unit or death = unfavorable evolution

Secondary

MeasureTime frameDescription
Modified Early Warning Score (MEWS)Hour 0Score allowing the classification of the urgency of a patient. The minimum value is 0 and the maximum value is 17. Higher scores mean a worse outcome
Blood supar levelsWhen the excepted 150 patients will be included, estimated 6 monthsthe supar values are classifies into three categories : \< 3 ng/ml : supports the referral decision. the patient's general condition is good and the prognosis is high 3-6 ng/ml : presence of pathologies and comorbidity factors. readmissions and high mortality beyond 6 months \>6 ng/ml : requires special clinical attention, high risk of mortality
Blood CRP valueHour 0the CRP value will be assessed during the blood test performed as part of the classical management when the patient arrives in the emergency room
Cardiac frequencyHour 0cardiac frequency will be evaluated when the patient arrives in the emergency service as part of the classical management
Respiratory rateHour 0respiratory rate will be evaluated when the patient arrives in the emergency service as part of the classical management
National Early Warning Score 2 (NEWS2)Hour 0Score allowing the classification of the urgency of a patient. The minimum value is 0 and the maximum value is 20. Higher scores mean a worse outcome
Systolic blood pressureHour 0systolic blood pressure will be evaluated when the patient arrives in the emergency service as part of the classical management
Diastolic blood pressureHour 0diastolic blood pressure will be evaluated when the patient arrives in the emergency service as part of the classical management
French triageHour 0French Emergency Nurses Classification in Hospitals (FRENCH) ranks priorities from 5 to 1 (from least urgent to most urgent) according to prognosis and complexity/severity of the medical condition
Main diagnosis retained by the physicianat the end of hospitalizationMain diagnosis retained
TemperatureHour 0the temperature will be evaluated when the patient arrives in the emergency service as part of the classical management

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026